Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
pfizer
adverum biotechnologies
alzheimer's disease
biotech ipos
bridgebio
cancer
What
bio
4
×
roundup
drug
crispr
patients
pricing
acquisitions
advanced
advantages
albert
alliance
arrival
award
bar
biggest
bourla
brings
bristol
buy
calls
cancer
ceo
changing
color
company
data
days
death
decades
dems
expect
future
gamble
given
growing
hours
immunotherapy
imports
kudos
leaves
Language
unset
unknown
Current search:
roche
×
bio
×
merck
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More